Table 1 Binding affinities as well as Lipinski's rule of five of top-10 HDAC6 inhibitors.

From: Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy

Drug name

Score

MW

HBD

HBA

RB

Rings

LogP

Bexarotene

− 10

348.4779

1

2

4

3

7.6

Capmatinib

− 9.5

412.428

1

5

5

5

2.9

Belinostat

− 9.4

318.35

3

4

7

2

1.6

Cyproheptadine

− 9.3

287.3981

0

0

0

4

4.2

Oxyphenisatin acetate

− 9.2

401.418

1

3

6

4

3.4

Acrivastine

− 9.2

348.4382

1

3

5

3

3.1

Ketotifen

− 9.1

309.425

0

1

0

4

3.2

Phenolphthalein

− 9.1

318.3228

2

3

4

4

3.8

Panobinostat

− 8.9

349.434

3

2

9

3

2.9

Bisoxatin

− 8.9

333.343

3

3

4

4

3.3

Reference inhibitor

− 8.1

302.37

4

2

6

1

2.7

  1. MW molecular weight, HBD hydrogen bond donor, HBA hydrogen bond acceptor, RB rotatable bonds.